HCAR2 and neoplasm: Butyric acid elevates IL-10 and retinoic acid levels in the intestinal microenvironment by binding to G-protein-coupled receptor 109A (GPR109A) on the surface of immune cells, thereby promoting the differentiation of initial T cells to regulatory T cells and facilitating their proliferation, this process effectively suppresses the pro-tumor inflammatory response [135].